$PYPD ($PYPD) posted quarterly earnings results for Q4 2025 on Wednesday, February 11th. The company reported earnings of -$0.41 per share, missing estimates of -$0.34 by $0.07. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $PYPD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
$PYPD Hedge Fund Activity
We have seen 7 institutional investors add shares of $PYPD stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AIGH CAPITAL MANAGEMENT LLC added 277,844 shares (+26.1%) to their portfolio in Q4 2025, for an estimated $1,205,842
- MORGAN STANLEY added 124,688 shares (+160.7%) to their portfolio in Q3 2025, for an estimated $415,834
- ADAR1 CAPITAL MANAGEMENT, LLC removed 103,950 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $346,673
- SYMMETRY PEAK MANAGEMENT LLC added 79,146 shares (+123.8%) to their portfolio in Q3 2025, for an estimated $263,951
- ROSALIND ADVISORS, INC. removed 56,794 shares (-5.8%) from their portfolio in Q3 2025, for an estimated $189,407
- XTX TOPCO LTD added 21,773 shares (+inf%) to their portfolio in Q3 2025, for an estimated $72,612
- GOLDMAN SACHS GROUP INC removed 14,292 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $62,027
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PYPD Analyst Ratings
Wall Street analysts have issued reports on $PYPD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Roth Capital issued a "Buy" rating on 11/13/2025
To track analyst ratings and price targets for $PYPD, check out Quiver Quantitative's $PYPD forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.